Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Amgen Inc. (AMGN) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (592)	7/10/1998 7:10:00 AM
From: Harold Engstrom	Respond to of 1906

Henry, thanks for the information and links. Harold

To: Henry Niman who wrote (592)	7/14/1998 8:44:00 PM
From: Void	Read Replies (3) \| Respond to of 1906

Henry-While it is obvious that you have definitely put some effort into your research and postings, I believe I detect somewhat of a bias. SOURCE: BioWorld Today DATE: July 14, 1998 "Although this compound does have, we believe, incredible effects in the mouse," Rosen observed, "in the assays we've done to date we have not seen activity in human systems. So we're going back to several drawing boards, looking at related molecules from the same series as well as discovery of additional ones that will be human-active." Back to the drawing board is quite a ways back.